Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 13, 2017
On Dec. 2, 2016, KEI hosted a meeting on the delinkage of the costs of research and development from the prices of drugs, vaccines, and diagnostics.
0:00:00 What is delinkage and why is it important? Moderator: Hannah Vogel, Legislative Assistant, Rep. Lloyd Doggett (D-Texas) Judit Rius Sanjuan, MSF Access Campaign Manon Ress, Union for Affordable Cancer Treatment (UACT)
0:24:15 Direct Funding and End Product Prizes Moderator: Sarah Karlin-Smith, POLITICO Aidan Hollis, Professor, Department of Economics, University of Calgary Joe Larsen, Ph.D., Deputy Director (Acting), Biomedical Advanced Research and Development Authority (BARDA) Dean Baker, Co-Director, Center for Economic and Policy Research (CEPR) James Love, Director, Knowledge Ecology International (KEI) Respondents: Patrick Kilbirde, Executive Director, Global Intellectual Property Center, U.S. Chamber of Commerce; and James L. McGee, Executive Director, Transit Employees' Health & Welfare Fund
1:35:21 Upstream Incentive Mechanisms, Open Source Dividend Moderator: Dan Vergano, BuzzFeed News Diane Singhroy, Scientific Advisor, KEI John Wilbanks, Chief Commons Officer, Sage Bionetworks, and Senior Fellow, Ewing Marion Kauffman Foundation and FasterCures Katy Athersuch, Medical Innovation & Access Policy Manager, MSF Tim Hubbard, Professor of Bioinformatics, King's College London
2:14:20 International Negotiations on Delinkage Moderator: Judit Rius Sanjuan, MSF Ellen 't Hoen, Medicines Law & Policy; Global Health Unit, University Medical Center Groningen, The Netherlands; and The Lancet Commission on Essential Medicines Policies Sakiko Fukuda-Parr, Professor of International Affairs, The New School, New York; and Member, United Nations Secretary-General's High-Level Panel on Access to Medicines Rachel Cohen, Executive Director, DNDi North America
2:39:01 Concluding Comments Moderators: Sophie Kasimow and Lori Kearns, Sen. Bernie Sanders (I-Vt.) Rishab Ghosh, Maastricht University Rob Weissman, President, Public Citizen Ellen 't Hoen James Love